Merck KGaA (ADR)

Factors to consider:

• Company pays dividends (annually): last record date 2025-04-29, amount 0.50$ (Y1.78%)
• Price in estimated range
• Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

• 2024-12-31 to 2025-12-31 estimated range: [22.60$, 35.43$]
• 2025-12-31 to 2026-12-31 estimated range: [23.15$, 36.17$]

Financial Metrics affecting the MKKGY estimates:

• Positive: with PPE of 13.4 at the end of fiscal year the price was neutral
• Positive: 7.86 < Operating profit margin, % of 17.23
• Negative: negative Industry operating cash flow (median)
• Positive: 6.82 < Operating cash flow per share per price, % of 7.63
• Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.11
• Negative: Investing cash flow per share per price, % of -5.08 <= -4.48
• Positive: 41.86 < Shareholder equity ratio, % of 58.01 <= 63.39
• Positive: Inventory ratio change, % of -0.60 <= 0
• Negative: 0.01 < Interest expense per share per price, % of 0.49